News

August 21, 2019August 21, 2019

Immune System Molecule IL-17A Likely Inflammatory Agent in RRMS, Study Says

News

Interleukin-17A (IL-17A), a molecule that mediates immune and inflammatory responses, likely promotes inflammation and tissue damage in relapsing-remitting multiple sclerosis (RRMS) and should be considered a potential target for ... Read more

August 21, 2019August 21, 2019

Gilenya, Aubagio, Tysabri, Tecfidera Dominate MS Therapy Switches in Europe, Spherix Survey Finds

News

Novartis‘ Gilenya (fingolimod), Sanofi Genzyme‘s Aubagio (teriflunomide), and Biogen’s Tysabri (natalizumab) and Tecfidera (dimethyl fumarate) are the top disease-modifying therapies to which patients with multiple sclerosis (MS) have most frequently switched in Europe ... Read more

August 20, 2019August 20, 2019

Exploring Early Treatment Strategies for RRMS: An Interview with Neurologist Daniel Ontaneda

News

When it comes to initial treatment selection for relapsing-remitting multiple sclerosis (RRMS), there is one question that has yet to be answered: Is it better to start with potentially ... Read more

August 20, 2019August 20, 2019

In Brains Damaged by MS or Age, Cells Can Be Tricked to Promote Remyelination, Study Suggests

News

Our brains — much like our joints — stiffen with age, causing brain stem cells called oligodendrocyte progenitor cells (OPCs) to lose their ability to proliferate and transform into ... Read more

August 19, 2019August 19, 2019

Imaging That Captures Damage to Brain in CIS Helps in Determining Likelihood of MS, Study Says

Alexa, News

Imaging techniques that measure damage to the brain, in addition to those that detect lesions, may be useful in predicting likely disease progression in people with clinically isolated syndrome ... Read more

August 19, 2019August 19, 2019

NHS ‘Toolkit’ Aims to Improve Care Given People with MS, Other Neurological Ills in UK

News

The National Health Service (NHS) England announced an initiative that aims to speed diagnoses and ensure better all-around care for people with progressive neurological conditions like multiple sclerosis (MS), Parkinson’s ... Read more

August 16, 2019

Wahls Seminar Provides Different Perspectives on Managing MS: A Nutritionist’s View

News

“Diet is profound. Lifestyle is profound. All patients should be taught how profound these things are.”  — Terry Wahls, MS thriver and founder of the Wahls Protocol  Western medicine ... Read more

August 16, 2019August 16, 2019

MS Therapies Among Limited Offerings Through AllianceRx Walgreens Prime

News

Medications for treating certain rare and chronic conditions,  including multiple sclerosis (MS), are now available from the specialty and home delivery pharmacy AllianceRx Walgreens Prime, the company announced. The ... Read more

August 16, 2019August 16, 2019

Dark Rimmed Brain Lesions May Be Signal of Aggressive Disease, NIH Study Says

News

Brain lesions appearing as dark rimmed, “smoldering” spots on imaging scans, representing active inflammation, may be a hallmark of more aggressive and disabling forms of multiple sclerosis (MS), researchers ... Read more

August 15, 2019

Specific Fats in Cerebrospinal Fluid of MS Patients May Be Telling Markers of Disease, Study Suggests

News

Testing for the types of fat (lipid) molecules present in the cerebrospinal fluid (CSF) of people with multiple sclerosis (MS) may be a very useful way to diagnose and ... Read more

August 14, 2019August 14, 2019

‘Burgers to Beat MS’ Fundraiser Set for Aug. 22 at A&W Restaurants Across Canada

News

The 11th annual “Burgers to Beat MS” day is set for Aug. 22 in Canada, with $2 from each purchase of an A&W Teen Burger going to the MS Society of Canada ... Read more

August 14, 2019August 14, 2019

US Agency Asked to OK Cannabinoid Shipments from Canada to Support Studies in MS, MMJ Announces

News

MMJ International Holdings, a pharmaceutical company whose focus is plant-derived cannabis products for therapeutic purposes, has requested permission to ship tetrahydrocannabinol (THC) and cannabidiol (CBD) from Canada to the ... Read more

August 13, 2019August 13, 2019

Study Shows Range of Psychological and Physical Problems in Opioid-addicted MS Patients

News

Opioid addiction increases the risk for a number of physical and psychological problems in people with multiple sclerosis (MS), a new study has found. The study, “Impact of opium ... Read more

August 13, 2019August 13, 2019

Smartphones Could Be Used to Make Tremor Research Easier, More Affordable, Study Finds

News

Smartphones could be used as an inexpensive and effective way to measure  tremors in mice, which may allow for more research on tremor medications, a new study reports. The ... Read more

August 12, 2019August 12, 2019

NICE and NHS England Oppose Sativex to Treat Spasticity in MS, Urge More Studies of Medical Cannabis

News

A draft guidance issued by the National Institute for Health and Care Excellence (NICE), a U.K. advisory board, and a review by England’s National Health Service (NHS) call for more ... Read more

August 12, 2019August 12, 2019

SyntheticMR’s Software Package Capable of Quickly Measuring Myelin in Brain Available in US

News

SyntheticMR‘s SyMRI NEURO, a software package that can segment and measure myelin volume in the brain, is now available for use by radiologists in the U.S. through an agreement ... Read more

August 9, 2019August 9, 2019

Harnessing T-cell Subtype May Suppress Immune Responses in MS, Study Suggests

News

Though known mainly for killing tumor and virally infected cells, a T-cell subtype may restrain immune responses and be protective in autoimmune diseases such as multiple sclerosis (MS), according ... Read more

August 9, 2019August 9, 2019

Music While Walking Makes MS Patients More Motivated and Less Mentally Drained, Study Suggests

News

People listening to music during an extended walk tend to sync their steps to its beat — and for those with multiple sclerosis (MS), such synchronization helps to overcome mental ... Read more

August 8, 2019August 19, 2019

Medical Marijuana Now Available to MS and Other Patients in Louisiana

News

Medical cannabis products, jointly developed by GB Sciences Louisiana (GBSL) and the Louisiana State University Agricultural Center’s (LSU AgCenter) Therapeutic Cannabis Program, are now available for purchase by qualified patients ... Read more

August 8, 2019August 8, 2019

Specific Mutation and Amino Acid Change Linked to MS Risk in Study from Japan

News

An amino acid change to phenylalanine, and a specific class I HLA gene variant are associated with greater risk for multiple sclerosis (MS), according to a study in Japanese patients. ... Read more

August 7, 2019August 7, 2019

Autoimmune Complications Associated with Lemtrada Solved Using Anti-CD20 Therapies, Case Studies Suggest

News

Relapsing-remitting multiple sclerosis (RRMS) patients treated with Lemtrada (alemtuzumab) may develop additional (secondary) autoimmune reactions. Anti-CD20 therapies, including rituximab or Ocrevus (ocrelizumab), are a potential treatment for Lemtrada-associated autoimmune complications in patients ... Read more

August 7, 2019August 7, 2019

FDA Approves Bracco’s Varibar Thin Liquid for Use in Imaging Tests for Dysphagia

News

The U.S. Food and Drug Administration (FDA) has approved Bracco Diagnostics’ oral suspension of barium sulfate, called Varibar Thin Liquid, for use as imaging agent to detect swallowing disorders known ... Read more

August 6, 2019August 6, 2019

Phase 1 Study Finds T20K, Plant Protein-derived Compound for MS, Safe and Tolerable, Cyxone Says

News

A Phase 1 clinical trial found T20K, Cyxone’s investigational plant protein-derived treatment for multiple sclerosis (MS), to be safe and well-tolerated in healthy men, and raising the possibility that it might work ... Read more

August 6, 2019August 6, 2019

Research Underway on Space Station Looking at Cellular Triggers of MS and Parkinson’s

News

An ongoing experiment at the International Space Station may help identify triggers for multiple sclerosis (MS) and Parkinson’s disease by studying how nerve cells and immune cells interact when exposed ... Read more

August 5, 2019August 8, 2019

Under-the-skin CBD Infusion With Valeritas’ h-Patch Device Prolongs Therapy Effects, Study Finds

News

Valeritas Holdings’ proprietary h-Patch device can be used to administer cannabidiol by an under-the-skin (subcutaneous) infusion, prolonging the time the medication remains in circulation in the body and maximizing ... Read more

August 5, 2019August 5, 2019

Vaccines Pose No Risk of Developing MS, Large Population Study in Germany Reports

News

Vaccines are not a risk factor for multiple sclerosis (MS), a large data analysis spanning more than 12,250 MS patients in Germany shows. Fewer vaccinations were given to people ... Read more

August 2, 2019August 5, 2019

MS Society, Parkinson’s UK Grant $3.6 Million to Digital Brain Bank

News

The Multiple Sclerosis (MS) and Parkinson’s Tissue Bank at Imperial College London, the largest brain and tissue bank in Europe, will receive £1.5 million (about $1.82 million) from the ... Read more

August 2, 2019August 2, 2019

Rewind Therapeutics Receives Research Grant to Develop New Remyelination Medicines for MS

News

The development of new medicines to treat myelin-related neurological diseases, such as multiple sclerosis (MS), has been given a boost by a €2.9 million (about $3.2 million) research grant ... Read more

August 1, 2019August 1, 2019

Rutgers Health Leading Program to Support MS Children

News

Rutgers Health is leading the Pediatric Multiple Sclerosis and Demyelinating Diseases Program, the only program in the state of New Jersey designed specifically to support children with multiple sclerosis ... Read more

August 1, 2019August 1, 2019

Oral Vumerity Easier on Gastrointestinal Tract Than Tecfidera, Phase 3 Trial Finds

News

Fewer and less severe gastrointestinal (GI) side effects were evident in relapsing-remitting multiple sclerosis (RRMS) patients taking the investigational oral treatment Vumerity (diroximel fumarate) twice a day compared to those ... Read more

July 31, 2019July 31, 2019

Surgery with Anesthesia Does Not Raise Person’s Risk of MS Relapse, Study Finds

News

No excessive relapse risk appears to exist for people with multiple sclerosis who undergo surgery that requires anesthesia, researchers report, challenging long-held assumptions associated with MS and surgery. Their single-site ... Read more

July 31, 2019July 31, 2019

3D Imaging of Brain Lesions May Spot Those Most Likely to Heal, Guiding Treatment

News

A new diagnostic method for multiple sclerosis (MS) that uses 3D analysis of a patient’s brain may be able to tell physicians which lesions there are more likely to heal ... Read more

July 30, 2019July 30, 2019

Early MRI Screening Can Predict Long-term MS Disability, Help Guide Treatment, Study Says

News

Routine screening through magnetic resonance imaging (MRI) of people with multiple sclerosis (MS) can predict long-term disease progression — leading to more certainty and informing better treatment choices, a 15-year ... Read more

July 30, 2019July 30, 2019

Ponesimod Fares Well in Phase 3 Trial for Relapsing MS, Janssen Announces

News

Janssen has announced positive, top-line results from its Phase 3 OPTIMUM study, testing the effectiveness and safety of ponesimod tablets, compared to Sanofi‘s Aubagio (teriflunomide), in adults with relapsing forms ... Read more

July 29, 2019August 2, 2019

Early Gilenya Treatment Lessens Disability Progression and Disease Activity in Young RRMS Patients, Study Shows

News

Early and continuous treatment with Gilenya (fingolimod) in young  people — those ages 30 years or younger — with relapsing-remitting multiple sclerosis (RRMS) decreases the risk of disability progression, ... Read more

July 29, 2019July 29, 2019

$1.83M NIH Grant Supports Trial into STEM, Learning and Memory Training for Adults with MS

News

The National Institutes of Health (NIH) awarded a $1.83 million grant to a Kessler Foundation researcher leading a clinical trial to test if a month-long cognitive training program can improve ... Read more

July 26, 2019August 12, 2019

Neuronal Circuit Likely Behind Chronic Itch in MS and Other Diseases Identified

News

The nerve cell circuit, stretching from the skin to the spinal cord, that is likely responsible for the persistent itching sensation  that can afflict people with multiple sclerosis (MS) ... Read more

July 26, 2019July 26, 2019

MS MindShift Campaign Uses Balloon Festival to Raise Awareness About MS Brain Health

News

Celgene and the Multiple Sclerosis Association of America (MSAA) are working together to bring the “MS MindShift: A New View of MS” campaign, which is raising awareness about the ... Read more

July 25, 2019July 25, 2019

Tecfidera Up Against Bafiertam in Phase 1 Study of GI Tolerability

News

A first healthy volunteer has enrolled in a randomized, double-blind Phase 1 study to compare the gastrointestinal (GI) tolerability and safety of oral Tecfidera to Bafiertam, an oral bioequivalent in ... Read more

July 25, 2019July 25, 2019

Abundant T-helper Cells Evident in MS Patients May Cause Inflammation, Study Reports

News

Scientists identified and “fingerprinted” a group of T-helper cells that are unusually numerous in the blood and central nervous system of people with relapsing-remitting multiple sclerosis (RRMS), and may ... Read more